India's Caplin Point at near 6-month high on Q4 profit growth
** Shares of Caplin Point Laboratories Ltd CAPL.NS rise as
much as 4.57% to 770 rupees, highest since Dec.6
** Pharma firm reports 29% Y/Y jump in Q4 profit on a 15%
increase in revenue from ops, while core profit margin expands
** Relative strength index is 74, suggesting the stock may
be overbought
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees